Type 2 Diabetes Clinical Trial
— DiacourseOfficial title:
Tailored Support for Type 2 Diabetes Patients With an Acute Coronary Event After Discharge From Hospital
| Verified date | July 2014 |
| Source | UMC Utrecht |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Netherlands: Medical Ethics Review Committee (METC) |
| Study type | Interventional |
Background: In type 2 diabetes mellitus patients, an acute coronary event (ACE) may result
in a decreased quality of life and increased distress. According to the American Diabetes
Association, transition from the acute care setting is a high-risk time for all patients,
but tailored support specific to diabetes is scarce in that period. The investigators
developed an intervention by a diabetes nurse to help diabetic patients reduce distress
after their first ACE. The intervention is based on Bandura's Social Cognitive Theory,
Leventhal's Common Sense Model, and on results of focus groups which were conducted to
define the needs and wishes of type 2 diabetes patients and their partners regarding
professional support after an ACE. The aim of this study is to evaluate the effectiveness of
the intervention to reduce distress. The hypothesis is that patients who receive the
intervention will have less diabetes related distress compared to the control group.
Methods/Design: Randomized controlled trial. Patients will be recruited directly after
discharge from hospital. A diabetes nurse will visit the patients in the intervention group
(n = 100) within three weeks after discharge from hospital, two weeks later and two months
later. The control group (n = 100) will receive a telephone consultation. The primary
outcome is diabetes related distress, measured with the Problem Areas in Diabetes
questionnaire (PAID). Secondary outcomes are quality of life, anxiety, depression, HbA1c,
blood pressure and lipids. Mediating variables are self-management, self-efficacy and
illness representations. Variables will be measured with questionnaires directly after
discharge from hospital and five months later. Biomedical variables will be obtained from
the records from the primary care physician and the hospital. Differences between groups in
change over time will be analyzed according to the intention-to-treat principle.
Discussion: Type 2 diabetes patients who experience a first ACE need tailored support after
discharge from the hospital. This trial will provide evidence of the effectiveness of a
supportive intervention to reduce distress in these patients.
| Status | Completed |
| Enrollment | 201 |
| Est. completion date | December 2013 |
| Est. primary completion date | December 2013 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - History of type 2 diabetes (>1 year) - Discharged from the hospital after a first acute coronary event defined as a Myocardial Infarction (MI), Coronary Artery Bypass Graft (CABG) procedure or Percutaneous Transluminal Coronary Angioplasty (PTCA) - Sufficient knowledge of the Dutch language Exclusion Criteria: - A serious illness or condition which will prevent full participation - Not able to fill in questionnaires |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
| Country | Name | City | State |
|---|---|---|---|
| Netherlands | Meander Medical Center | Amersfoort | |
| Netherlands | Gelre Hospitals | Apeldoorn | |
| Netherlands | Lievensberg Hospital | Bergen op Zoom | |
| Netherlands | Amphia Hospital | Breda | |
| Netherlands | Gemini Hospital | Den Helder | |
| Netherlands | Admiraal de Ruyter Hospital | Goes | |
| Netherlands | Beatrix Hospital | Gorinchem | |
| Netherlands | Westfriesgasthuis | Hoorn | |
| Netherlands | Sint Antonius Hospital | Nieuwegein | |
| Netherlands | Canisius Wilhelmina Hospital | Nijmegen | |
| Netherlands | Diakonessenhuis | Utrecht | |
| Netherlands | Sint Antonius Hospital | Utrecht | |
| Netherlands | University Medical Center | Utrecht |
| Lead Sponsor | Collaborator |
|---|---|
| UMC Utrecht | Dutch Diabetes Research Foundation |
Netherlands,
Kasteleyn MJ, Gorter KJ, Stellato RK, Rijken M, Nijpels G, Rutten GE. Tailored support for type 2 diabetes patients with an acute coronary event after discharge from hospital - design and development of a randomised controlled trial. Diabetol Metab Syndr. 2014 Jan 18;6(1):5. doi: 10.1186/1758-5996-6-5. — View Citation
Kasteleyn MJ, Gorter KJ, van Puffelen AL, Heijmans M, Vos RC, Jansen H, Rutten GE. What follow-up care and self-management support do patients with type 2 diabetes want after their first acute coronary event? A qualitative study. Prim Care Diabetes. 2014 Oct;8(3):195-206. doi: 10.1016/j.pcd.2013.12.001. Epub 2014 Jan 3. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Change in Self-efficacy | Measured with the Confidence in Diabetes Self-care questionnaire consisting of 20 items measuring diabetes specific self-efficacy. | At 2 weeks and 5 months after discharge from hospital | No |
| Other | Change in Illness perceptions | Measured with the Illness Perception Questionnaire (IPQ) - short version. Questionnaire assessing the cognitive representation of illness, focuses on seven scales, assessing (1) Timeline acute/chronic and (2) Timeline cyclical (3) Consequences (4) Personal control (5) Treatment control (6) Illness coherence (7) Emotional representation | At 2 weeks and 5 months after discharge from hospital | No |
| Other | Change in Spousal support | Measured with the Active Engagement, Protective Buffering and Overprotection (ABO) questionnaire. Five items measure active engagement, eight items measure protective buffering and six items measure overprotection | At 2 weeks and 5 months after discharge from hospital | No |
| Primary | Change in Diabetes related distress | Diabetes related distress measure with the Problem Areas in Diabetes (PAID) questionnaire. The PAID is a Self-reported questionnaire consisting of twenty statements identified as common negative emotions related to living with diabetes. Each item is rated on a 5-point Likert scale, ranging from 0 ("not a problem") to 4 ("a serious problem"). The total score is transformed to a 0-100 scale, with higher score representing higher distress. | At 2 weeks and 5 months after discharge from hospital | No |
| Secondary | Change in Well-being | Measured with the WHO-Five Well-being Index (WHO-5). The five items covering positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interests (being interested in things) in the past two weeks | At 2 weeks and 5 months after discharge from hospital | No |
| Secondary | Change in Quality of life | Euroqol 5 Dimensions (EQ-5D) and the Euroqol Visual Scale (EQ-VAS). The EQ-5D measures general health status on five dimensions: Mobility Self-care Usual activities Pain/discomfort Anxiety/depression The EQ-VAS measures the overall health state on a graded, vertical line. |
At 2 weeks and 5 months after discharge from hospital | No |
| Secondary | Change in Anxiety and depression | Measured with the Hospital Anxiety and Depression Scale (HADS). A questionnaire measuring anxiety (7 items) and depression (7 items). | At 2 weeks and 5 months after discharge from hospital | No |
| Secondary | Change in Physical activity | Measured with the International Physical Activity Questionnaire (IPAQ). 29 Items measure how many days' physical activities are performed during the past seven days in four domains (work, transportation, housework and leisure-time). | At 2 weeks and 5 months after discharge from hospital | No |
| Secondary | Change in Self care | Measured with the Summary of the Diabetes Self-Care Activities Measure (SDSCA). Eleven items assessing several aspects of the diabetes regimen: general diet, specific diet, exercise, blood glucose testing, foot care, and smoking. Items measure how many days a patient has performed self-care activities in the last seven days. | At 2 weeks and 5 months after discharge from hospital | No |
| Secondary | Change in Diabetes coping | Measured with the Diabetes Coping Measure (DCM) consisting of four scales measuring diabetes coping: tackling spirit, avoidance, passive resignation and diabetes integration. | At 2 weeks and 5 months after discharge from hospital | No |
| Secondary | Change in Biomedical variables | Blood pressure, blood lipids (total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides) and body mass index | At 2 weeks and 5 months after discharge from hospital | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
| Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
| Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
| Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
| Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
| Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
| Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
| Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
| Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
| Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |